Our CBO, Heidi Kingdon Jones and Director of Business Development, NA, French Lewis, III will be in attendance and ready to answer all your questions about how our iPSC-derived Hepatocytes can overcome the drawbacks of primary cells. We look forward to joining you for two days of ground-breaking insights, networking and collaboration.
